1. Murray PR, Drew LW, Kobayashi GS, Thompson JH: Medical microbiology. CV Mosby, St. Louis, MO, 1990, p. 119–126.
2. Buckley MM, Brogden RN, Barradell LB, Goa KL: Imipenem/cilastatin. A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1992, 44: 408–444.
3. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. M7-A2. NCCLS, Villanova, PA, 1990.
4. Garner JS, Jarwis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections. Journal of Infection Control 1988, 16: 128–140.
5. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC: Diagnostic microbiology. 4th ed. J.B. Lippincott, Philadelphia, 1992, p. 186–211.